GI
GILD icon

GLOBALT Investments’s Gilead Sciences GILD Stock Holding History

GLOBALT Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Sell
53,145
-901
-2% -$119K 0.23% 55
2026
Q1 		$7.53M Sell
54,046
-1,450
-3% -$203K 0.27% 50
2025
Q4 		$6.81M Buy
55,496
+7,078
+15% +$860K 0.25% 54
2025
Q3 		$5.37M Sell
48,418
-1,004
-2% -$114K 0.2% 70
2025
Q2 		$5.48M Buy
49,422
+1,195
+2% +$127K 0.21% 66
2025
Q1 		$5.4M Sell
48,227
-432
-0.9% -$44.6K 0.22% 68
2024
Q4 		$4.49M Buy
48,659
+8,204
+20% +$739K 0.17% 78
2024
Q3 		$3.39M Sell
40,455
-1,992
-5% -$152K 0.13% 90
2024
Q2 		$2.91M Sell
42,447
-510
-1% -$34K 0.12% 100
2024
Q1 		$3.15M Sell
42,957
-1,012
-2% -$77.8K 0.13% 92
2023
Q4 		$3.56M Buy
+43,969
New +$3.42M 0.15% 88

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GLOBALT Investments's GILD Position: Q2 2026 in Review

GLOBALT Investments reduced its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, selling an estimated $119K and leaving 53,145 shares worth $6.71M. The position accounts for 0.23% of the portfolio, ranked #55.

GLOBALT Investments first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.53M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • GLOBALT Investments held 53,145 shares of Gilead Sciences worth $6.71M as of Q2 2026.
  • GLOBALT Investments sold 901 Gilead Sciences shares in Q2 2026, an estimated $119K.
  • Gilead Sciences made up 0.23% of GLOBALT Investments's portfolio in Q2 2026, its #55 holding.
  • GLOBALT Investments first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • GLOBALT Investments's Gilead Sciences position peaked at $7.53M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on GLOBALT Investments's 13F filing for Q2 2026, filed 11 Aug 2026.